THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Wednesday reported a loss of $74.6 million in its fourth quarter.On a per-share basis, the Thousand Oaks, California-based company said it had a loss of 72 cents.The drug developer posted revenue of $221,000 in the period.Atara Biotherapeutics shares have climbed 54% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.04, a decrease of 67% in the last 12 months._____This story was generated by  Automated Insights  (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a  Zacks stock report on ATRA  at https://www.zacks.com/ap/ATRA